Skip to main content
SpringerLink
Log in

IDEAL results: earlier initiation of dialysis yields cost savings in Australia and New Zealand

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Dansie KB, et al. The IDEAL trial in Australia and New Zealand: Clinical and Economic impact. Nephrology Dialysis Transplantation : 28 Sep 2021. Available from: URL: http://doi.org/10.1093/ndt/gfab270

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

IDEAL results: earlier initiation of dialysis yields cost savings in Australia and New Zealand. PharmacoEcon Outcomes News 889, 14 (2021). https://doi.org/10.1007/s40274-021-08102-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-08102-2

Search

Navigation